Seattle Diabetes Biorepository
What is the Diabetes Biorepository?
The Diabetes Biorepository is a confidential list of people with type 1 diabetes who donate a blood sample and provide health information for scientific research. We invite you to participate in this research study to help us improve our understanding of diabetes and immune mediated diseases. BRI's Diabetes Biorepository is also known as The BRIDGE Study. The study consists of a computer registry where we store your contact, research and health information and a sample repository where we keep blood and other biologic samples for current and future use in our research.
To learn more BRI's type 1 diabetes research, please visit the Type 1 Diabetes clinical research page.
What are BRI scientists studying?
Researchers at Benaroya Research Institute (BRI) are involved in studying multiple aspects of the immune system and its relation to type 1 diabetes. While some research is conducted in models of diabetes, many researchers study human blood samples to gain a better understanding of the disease. Blood samples donated by patients with type 1 diabetes and family members are crucial to continuing this research.
To learn more about this subject, please visit the Type 1 Diabetes disease information page.
Who can participate?
We are currently enrolling individuals with type 1 diabetes.
How can I help?
Participation in this study consists of visiting BRI to give blood samples and answer questions about personal and family medical history. The blood samples are used to investigate genetic markers associated with autoimmune disease, and to study measures of autoimmunity such as antibodies and immune system activity. Individuals who were diagnosed with type 1 diabetes less than two years ago may be asked to participate in additional tests. Participation in this study is completely voluntary and is of no direct benefit to participants. All information obtained is kept strictly confidential.
Benaroya Research Institute Diabetes Clinical Research Program